ES2455440T3 - Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas - Google Patents

Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas Download PDF

Info

Publication number
ES2455440T3
ES2455440T3 ES10196249.6T ES10196249T ES2455440T3 ES 2455440 T3 ES2455440 T3 ES 2455440T3 ES 10196249 T ES10196249 T ES 10196249T ES 2455440 T3 ES2455440 T3 ES 2455440T3
Authority
ES
Spain
Prior art keywords
immunoglobulins
iga
antibody
light chains
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES10196249.6T
Other languages
English (en)
Spanish (es)
Inventor
Arthur Bradwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Application granted granted Critical
Publication of ES2455440T3 publication Critical patent/ES2455440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES10196249.6T 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas Expired - Lifetime ES2455440T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
GB0501741 2005-01-27

Publications (1)

Publication Number Publication Date
ES2455440T3 true ES2455440T3 (es) 2014-04-15

Family

ID=34259791

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10196249.6T Expired - Lifetime ES2455440T3 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas
ES06703629.3T Active ES2365626T7 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES06703629.3T Active ES2365626T7 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas

Country Status (11)

Country Link
US (3) US7897353B2 (enExample)
EP (2) EP1842071B3 (enExample)
JP (3) JP5431674B2 (enExample)
AT (1) ATE502302T1 (enExample)
DE (1) DE602006020688D1 (enExample)
DK (1) DK2306202T3 (enExample)
ES (2) ES2455440T3 (enExample)
GB (1) GB0501741D0 (enExample)
PL (1) PL2306202T3 (enExample)
PT (1) PT2306202E (enExample)
WO (1) WO2006079816A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
MA33256B1 (fr) 2009-04-01 2012-05-02 Genentech Inc Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) * 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
PT3387898T (pt) * 2013-03-15 2020-06-17 Mayo Found Medical Education & Res Identificação e monitorização de imunoglobulinas monoclonais pela massa molecular
WO2015035132A1 (en) 2013-09-06 2015-03-12 Sensor Electronic Technology, Inc. Ultraviolet diffusive illumination
JP6759104B2 (ja) 2014-04-04 2020-09-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 精密分子質量を用いた免疫グロブリンのアイソタイピング
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
JPS57501147A (enExample) 1980-07-16 1982-07-01
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
ES2150428T3 (es) 1987-04-27 2000-12-01 Unilever Nv Ensayos de union especifica.
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
WO1997017372A1 (en) 1995-11-03 1997-05-15 The Binding Site Limited Production of antibodies, and medical uses involving antibodies
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
CA2349290A1 (en) * 1998-11-19 2000-06-02 Elan Corporation, Plc Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
JP2004520055A (ja) * 2001-02-20 2004-07-08 ジェンセット Ｐｇ−３およびｐｇ−３の二対立遺伝子マーカー
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
EP1449851A4 (en) * 2001-11-27 2005-11-16 Mochida Pharm Co Ltd NEUTRALIZING ANTIBODIES OF IL13 ALPHA RECEPTOR 1
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
CA2860151A1 (en) * 2003-02-10 2004-08-26 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
US7662387B2 (en) * 2003-02-20 2010-02-16 Seattle Genetics Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
CA2519113C (en) * 2003-04-02 2012-06-05 F. Hoffmann-La Roche Ag Antibodies against insulin-like growth factor i receptor and uses thereof
JP4286256B2 (ja) * 2003-11-19 2009-06-24 ヤマサ醤油株式会社 ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
US8415110B2 (en) 2013-04-09
JP2014025950A (ja) 2014-02-06
EP2306202A1 (en) 2011-04-06
ES2365626T7 (es) 2014-06-04
US20080166742A1 (en) 2008-07-10
DE602006020688D1 (de) 2011-04-28
JP6007134B2 (ja) 2016-10-12
EP1842071B1 (en) 2011-03-16
US20110177977A1 (en) 2011-07-21
JP5431674B2 (ja) 2014-03-05
DK2306202T3 (da) 2014-02-10
PT2306202E (pt) 2014-02-27
WO2006079816A1 (en) 2006-08-03
US7897353B2 (en) 2011-03-01
JP2008528995A (ja) 2008-07-31
ES2365626T3 (es) 2011-10-07
US8592561B2 (en) 2013-11-26
EP1842071A1 (en) 2007-10-10
PL2306202T3 (pl) 2014-05-30
GB0501741D0 (en) 2005-03-02
ATE502302T1 (de) 2011-04-15
US20110177535A1 (en) 2011-07-21
EP1842071B3 (en) 2014-02-26
JP2013147499A (ja) 2013-08-01
JP5715671B2 (ja) 2015-05-13
EP2306202B1 (en) 2013-12-18

Similar Documents

Publication Publication Date Title
JP6007134B2 (ja) 免疫グロブリン重鎖−軽鎖対に特異的である単離抗体又はその断片
US20160341721A1 (en) Anti-human igm monoclonal antibody and immunoassay using the same
US20110312922A1 (en) EDTA Resistant S100A12 Complexes (ERAC)
CA2755486A1 (en) Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer
US20150285804A1 (en) Diagnostic method for colorectal cancer
US20220221469A1 (en) Mass Spectrometry Calibrator
US11242408B2 (en) Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
JPWO2008099608A1 (ja) 炎症性腸疾患の診断方法
CN107076760A (zh) 用于评估先兆子痫的生物标志物
JP7671956B2 (ja) 抗原の測定方法及び固相化抗体の製造方法
JP2013519082A (ja) がん予後診断アッセイ
Pande Immunochemistry Techniques
CN118786347A (zh) 丝氨酸蛋白酶的检测用或测定用试剂
WO2017170847A1 (ja) 糖尿病の罹患を測定する方法
Leach et al. False reactivity in GTI Pak Plus® ELISA kits due to the presence of anti-mouse antibody in patients’ samples
WO2022202876A1 (ja) Ｉ型コラーゲンｃ末端テロペプチドの免疫学的分析方法
JPH10307142A (ja) 抗ヘリコバクター・ピロリ抗体測定試薬及び該試薬を用いる測定方法